Plasma fibronectin supports hemostasis and regulates thrombosis

Journal of Clinical Investigation

Volumn 124, Issue 10, 2014, Pages 4281-4293

  Wang, Yiming ^a,b,c   Reheman, Adili ^b   Spring, Christopher M ^b   Kalantari, Jalil ^a,b   Marshall, Alexandra H ^b   Wolberg, Alisa S ^d   Gross, Peter L ^e   Weitz, Jeffrey I ^e   Rand, Margaret L ^a,f   Mosher, Deane F ^g   Freedman, John ^a,b   Ni, Heyu ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e MCMASTER UNIVERSITY   (Canada)

^f HOSPITAL FOR SICK CHILDREN   (Canada)

^g UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BETA3 INTEGRIN; FIBRIN; FIBRINOGEN; FIBRONECTIN; PLASMA FIBRONECTIN; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULANT THERAPY; ARTICLE; BLOOD VESSEL OCCLUSION; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOTHELIUM; FEMALE; FIBRIN CLOT; HEMOSTASIS; MALE; MOUSE; NONHUMAN; PLASMA; REGULATORY MECHANISM; SCANNING ELECTRON MICROSCOPY; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTE MEMBRANE; THROMBOELASTOGRAPHY; THROMBOSIS; ANIMAL; BLOOD; BLOOD CLOTTING; CHEMISTRY; CONFOCAL MICROSCOPY; HOMEOSTASIS; HUMAN; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; TRANSGENIC MOUSE; TREATMENT OUTCOME;

ANIMALS; BLOOD COAGULATION; BLOOD PLATELETS; FEMALE; FIBRIN; FIBRINOGEN; FIBRONECTINS; HEMOSTASIS; HOMEOSTASIS; HUMANS; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, SCANNING; THROMBOSIS; TREATMENT OUTCOME;

EID: 84907487892     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI74630     Document Type: Article

References (57)

1. Hynes RO. Hemostasis and thrombosis. In: Hynes RO, ed. Fibronectins. New York, New York, USA: Springer New York; 1990:335-348.
2. Savage B, Almus-Jacobs F, Ruggeri ZM. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell. 1998;94(5):657-666.
3. Ni H, Freedman J. Platelets in hemostasis and thrombosis: role of integrins and their ligands. Transfus Apher Sci. 2003;28(3):257-264.
4. Ruggeri ZM. Platelets in atherothrombosis. Nat Med. 2002;8(11):1227-1234.
5. George EL, Georges-Labouesse EN, Patel-King RS, Rayburn H, Hynes RO. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development. 1993;119(4):1079-1091.
6. Zerlauth G, Wolf G. Plasma fibronectin as a marker for cancer and other diseases. Am J Med. 1984;77(4):685-689.
7. Tomasini-Johansson B, Mosher DF. Plasma fibronectin concentration in inbred mouse strains. Thromb Haemost. 2009;102(6):1278-1280.
8. Mosher DF, Schad PE. Cross-linking of fibronectin to collagen by blood coagulation Factor XIIIa. J Clin Invest. 1979;64(3):781-787.
9. Moretti FA, Chauhan AK, Iaconcig A, Porro F, Baralle FE, Muro AF. A major fraction of fibronectin present in the extracellular matrix of tissues is plasma-derived. J Biol Chem. 2007;282(38):28057-28062.
10. Mosher DF. Cross-linking of cold-insoluble globulin by fibrin-stabilizing factor. J Biol Chem. 1975;250(16):6614-6621.
11. Doolittle RF. Step-by-step evolution of vertebrate blood coagulation. Cold Spring Harb Symp Quant Biol. 2009;74:35-40.
12. Tucker RP, Chiquet-Ehrismann R. Evidence for the evolution of tenascin and fibronectin early in the chordate lineage. Int J Biochem Cell Biol. 2009;41(2):424-434.
13. Ghosh A, et al. Characterization of zebrafish von Willebrand factor reveals conservation of domain structure, multimerization, and intracellular storage. Adv Hematol. 2012;2012:214209.
14. McKeown-Longo PJ, Mosher DF. Binding of plasma fibronectin to cell layers of human skin fibroblasts. J Cell Biol. 1983;97(2):466-472.
15. Olorundare OE, Peyruchaud O, Albrecht RM, Mosher DF. Assembly of a fibronectin matrix by adherent platelets stimulated by lysophosphatidic acid and other agonists. Blood. 2001;98(1):117-124.
16. Cho J, Mosher DF. Characterization of fibronectin assembly by platelets adherent to adsorbed laminin-111. J Thromb Haemost. 2006;4(5):943-951.
17. Ni H, Papalia JM, Degen JL, Wagner DD. Control of thrombus embolization and fibronectin internalization by integrin alpha IIb beta 3 engagement of the fibrinogen gamma chain. Blood. 2003;102(10):3609-3614.
18. Ni H, et al. Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. J Clin Invest. 2000;106(3):385-392.
19. Ni H, et al. Plasma fibronectin promotes thrombus growth and stability in injured arterioles. Proc Natl Acad Sci U S A. 2003;100(5):2415-2419.
20. Cho J, Mosher DF. Role of fibronectin assembly in platelet thrombus formation. J Thromb Haemost. 2006;4(7):1461-1469.
21. Sakai T, et al. Plasma fibronectin supports neuronal survival and reduces brain injury following transient focal cerebral ischemia but is not essential for skin-wound healing and hemostasis. Nat Med. 2001;7(3):324-330.
22. Yang H, et al. Fibrinogen and von Willebrand factor-independent platelet aggregation in vitro and in vivo. J Thromb Haemost. 2006;4(10):2230-2237.
23. Zhai Z, et al. Fibrinogen controls human platelet fibronectin internalization and cell-surface retention. J Thromb Haemost. 2007;5(8):1740-1746.
24. Xu X, et al. A novel fibrinogen Bbeta chain frameshift mutation in a patient with severe congenital hypofibrinogenaemia. Thromb Haemost. 2006;95(6):931-935.
25. Reheman A, et al. Plasma fibronectin depletion enhances platelet aggregation and thrombus formation in mice lacking fibrinogen and von Willebrand factor. Blood. 2009;113(8):1809-1817.
26. Falati S, Gross P, Merrill-Skoloff G, Furie BC, Furie B. Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat Med. 2002;8(10):1175-1181.
27. Stalker TJ, et al. Hierarchical organization in the hemostatic response and its relationship to the platelet-signaling network. Blood. 2013;121(10):1875-1885.
28. Webster ML, et al. Relative efficacy of intravenous immunoglobulin G in ameliorating thrombocytopenia induced by antiplatelet GPIIbIIIa versus GPIbalpha antibodies. Blood. 2006;108(3):943-946.
29. Moon DG, Kaplan JE, Mazurkewicz JE. The inhibitory effect of plasma fibronectin on collagen-induced platelet aggregation. Blood. 1986;67(2):450-457.
30. Santoro SA. Inhibition of platelet aggregation by fibronectin. Biochem Biophys Res Commun. 1983;116(1):135-140.
31. Dixit VM, et al. Inhibition of platelet aggregation by a monoclonal antibody against human fibronectin. Proc Natl Acad Sci U S A. 1985;82(11):3844-3848.
32. Thurlow PJ, Kenneally DA, Connellan JM. The role of fibronectin in platelet aggregation. Br J Haematol. 1990;75(4):549-556.
33. Furie B, Flaumenhaft R. Thiol isomerases in thrombus formation. Circ Res. 2014;114(7):1162-1173.
34. Beumer S, Heijnen HF, IJsseldijk MJ, Orlando E, De Groot PG, Sixma JJ. Platelet adhesion to fibronectin in flow: the importance of von Willebrand factor and glycoprotein Ib. Blood. 1995;86(9):3452-3460.
35. Kamykowski GW, Mosher DF, Lorand L, Ferry JD. Modification of shear modulus and creep compliance of fibrin clots by fibronectin. Biophys Chem. 1981;13(1):25-28.
36. Okada M, Blomback B, Chang MD, Horowitz B. Fibronectin and fibrin gel structure. J Biol Chem. 1985;260(3):1811-1820.
37. Niewiarowska J, Cierniewski CS. Inhibitory effect of fibronectin on the fibrin formation. Thromb Res. 1982;27(5):611-618.
38. Procyk R, King RG. The elastic modulus of fibrin clots and fibrinogen gels: the effect of fibronectin and dithiothreitol. Biopolymers. 1990;29(3):559-565.
39. Collet JP, et al. The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis. Blood. 2005;106(12):3824-3830.
40. Arneson MA, Hammerschmidt DE, Furcht LT, King RA. A new form of Ehlers-Danlos syndrome. Fibronectin corrects defective platelet function. JAMA. 1980;244(2):144-147.
41. Dunne E, et al. Cadherin 6 has a functional role in platelet aggregation and thrombus formation. Arterioscler Thromb Vasc Biol. 2012;32(7):1724-1731.
42. Wang Y, et al. Platelets in thrombosis and hemostasis: old topic with new mechanisms. Cardiovasc Hematol Disord Drug Targets. 2012;12(2):126-132.
43. Brass LF, Wannemacher KM, Ma P, Stalker TJ. Regulating thrombus growth and stability to achieve an optimal response to injury. J Thromb Haemost. 2011;9(suppl 1):66-75.
44. Cho J, Mosher DF. Impact of fibronectin assembly on platelet thrombus formation in response to type I collagen and von Willebrand factor. Blood. 2006;108(7):2229-2236.
45. Cho J, Mosher DF. Enhancement of thrombogenesis by plasma fibronectin cross-linked to fibrin and assembled in platelet thrombi. Blood. 2006;107(9):3555-3563.
46. Cho J, Degen JL, Coller BS, Mosher DF. Fibrin but not adsorbed fibrinogen supports fibronectin assembly by spread platelets. Effects of the interaction of alphaIIb beta3 with the C terminus of the fibrinogen gamma-chain. J Biol Chem. 2005;280(42):35490-35498.
47. Melloni C, et al. Gibler WB, Ohman EM, and Peterson ED. Unfractionated heparin dosing and risk of major bleeding in non-ST-segment elevation acute coronary syndromes. Am Heart J. 2008;156(2):209-215.
48. Shirakami A, et al. Plasma fibronectin deficiency in eight members of one family. Lancet. 1986;1(8479):473-474.
49. Chen J, et al. N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice. J Clin Invest. 2011;121(2):593-603.
50. Yang H, et al. Fibrinogen is required for maintenance of platelet intracellular and cell-surface P-selectin expression. Blood. 2009;114(2):425-436.
51. Li C, et al. The maternal immune response to fetal platelet GPIbalpha causes frequent miscarriage in mice that can be prevented by intravenous IgG and anti-FcRn therapies. J Clin Invest. 2011;121(11):4537-4547.
52. Ni H, Ramakrishnan V, Ruggeri ZM, Papalia JM, Phillips DR, Wagner DD. Increased thrombogenesis and embolus formation in mice lacking glycoprotein V. Blood. 2001;98(2):368-373.
53. Lei X, et al. Anfibatide, a novel GPIb complex antagonist, inhibits platelet adhesion and thrombus formation in vitro and in vivo in murine models of thrombosis. Thromb Haemost. 2014;111(2):279-289.
54. Sachs UJ, Nieswandt B. In vivo thrombus formation in murine models. Circ Res. 2007;100(7):979-991.
55. Yang Y, et al. Plant food delphinidin-3-glucoside significantly inhibits platelet activation and thrombosis: novel protective roles against cardiovascular diseases. PloS One. 2012;7(5):e37323.
56. Reheman A, et al. Vitronectin stabilizes thrombi and vessel occlusion but plays a dual role in platelet aggregation. J Thromb Haemost. 2005;3(5):875-883.
57. Campbell RA, Overmyer KA, Selzman CH, Sheridan BC, Wolberg AS. Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stability. Blood. 2009;114(23):4886-4896.